Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2014
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889267 Organic light emitting device
11/13/2014US20140336393 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
11/13/2014US20140336382 Tyrosine kinase inhibitors
11/13/2014US20140336381 Fast-dissociating dopamine 2 receptor antagonists
11/13/2014US20140336380 Process for the preparation of agomelatine
11/13/2014US20140336207 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof
11/13/2014US20140336206 Inhibitors of bruton's tyrosine kinase
11/13/2014US20140336203 Crystalline forms of a bruton's tyrosine kinase inhibitor
11/13/2014US20140336197 SUBSTITUTED IMIDAZO [1,5-a]QUINOXALINES AS A PDE9 INHIBITOR
11/13/2014US20140336196 Phosphoric acid salts of sitagliptin
11/13/2014US20140336195 Aryloxmethyl cyclopropane derivatives as pde10 inhibitors
11/13/2014US20140336189 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
11/13/2014US20140336184 Method to enhance cognition
11/13/2014US20140336177 Inhibitors of the renal outer medullary potassium channel
11/13/2014US20140336173 Disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors
11/13/2014US20140336169 Imidazopyrazine syk inhibitors
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8884018 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
11/11/2014US8884014 Method for purifying a fused pyrrolocarbazole derivative
11/11/2014US8884005 Method for the preparation of carbapenam compounds
11/11/2014US8883889 Pigment compositions comprising pyrrolo[3,4-c]pyrroles
11/11/2014US8883837 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/11/2014US8883828 2-aminopyridine analogs as glucokinase activators
11/11/2014US8883821 Substituted pyrazolo[3,4-b]pyridines as medicaments
11/11/2014US8883807 Piperidinone carboxamide indane CGRP receptor antagonists
11/11/2014US8883806 Processes for preparing JAK inhibitors and related intermediate compounds
11/11/2014US8883803 Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
11/11/2014US8883801 Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
11/11/2014US8883799 Tricyclic PI3K inhibitor compounds and methods of use
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883788 Fused heterocyclic ring compound
11/11/2014US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/11/2014US8883432 Coelenterazine analogues and coelenteramide analogues
11/06/2014US20140330014 Imidazotriazinone compounds
11/06/2014US20140330000 Molecular Cartesian-Coordinate Platforms
11/06/2014US20140329876 Pyrazoline derivatives and their use as selective androgen receptor modulators
11/06/2014US20140329840 Molecules with potent dhfr binding affinity and antibacterial activity
11/06/2014US20140329838 Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptors
11/06/2014US20140329823 Dimeric IAP Inhibitors
11/06/2014US20140329820 Triazine Derivatives
11/06/2014US20140329807 Heterocyclic protein kinase inhibitors
11/06/2014US20140329805 Dual small molecule inhibitors of cancer and angiogenesis
11/06/2014US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877961 Bridged monobactam intermediates
11/04/2014US8877797 Methods for treating Parkinson's disease using pro-neurogenic compounds
11/04/2014US8877796 Spiro-oxindole MDM2 antagonists
11/04/2014US8877795 Identification of stabilizers of multimeric proteins
11/04/2014US8877785 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
11/04/2014US8877783 Isoxazolo-pyridine derivatives
11/04/2014US8877782 Isoxazolo-pyridine derivatives
11/04/2014US8877772 Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors
11/04/2014US8877763 Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
11/04/2014US8877761 N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors
11/04/2014US8877745 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/04/2014US8877171 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
10/2014
10/30/2014US20140323717 Methods for Preparing Functional Tetraazacycloalkane Compounds using a Specific Cyclic Bisaminal Compound
10/30/2014US20140323504 Pyrazolo[4,3-c]Pyridine Derivatives As Kinase Inhibitors
10/30/2014US20140323489 Hybrid necroptosis inhibitors
10/30/2014US20140323485 N-Substituted Heterocyclyl Carboxamides
10/30/2014US20140323475 Ep1 receptor ligands
10/30/2014US20140323470 Kinase inhibitors
10/30/2014US20140323465 Hcv protease inhibitors and uses thereof
10/30/2014US20140323464 Kinase inhibitors
10/30/2014US20140323462 Azetidine compounds, compositions and methods of use
10/30/2014US20140323438 Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/30/2014US20140322229 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/30/2014US20140322133 Tspo-targeting compounds and uses thereof
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871929 Fused-imidazoyl compounds useful as antimicrobial agents
10/28/2014US8871928 Tricyclic compounds, preparation methods, and their uses
10/28/2014US8871926 Synthesis of porphyrin nanostructures
10/28/2014US8871798 Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
10/28/2014US8871781 Methods and compositions for treating a subject for a lymphatic malformation
10/28/2014US8871776 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
10/28/2014US8871770 Carboxamide compounds and methods for using the same
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871767 2-arylimidazo[1,2-B]pyridazine, 2-phenylimidazo[1,2-A]pyridine, and 2-phenylimidazo[1,2-A]pyrazine derivatives
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/28/2014US8871761 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
10/28/2014US8871760 [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
10/28/2014US8871756 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/23/2014US20140315960 Prodrugs of non-steroid anti-inflammatory agents (nsaids)
10/23/2014US20140315931 Deazapurines useful as inhibitors of janus kinases
10/23/2014US20140315928 Substituted amide compounds
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315911 Dihydropteridinones
10/23/2014US20140315909 3,5-(Un)substituted-1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H- pyrrolo[2,3-b]pyrazine dual ITK and JAK3 Kinase Inhibitors
10/23/2014US20140315908 PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO[2,3-b]PYRAZIN-2(1H)-ONE
10/23/2014US20140315907 Treatment of cancer with dihydropyrazino-pyrazines
10/23/2014US20140315889 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315883 6H-IMIDAZO[1,5-a]PYRROLO[2,3-e]PYRAZINE COMPOUNDS
10/23/2014US20140315880 3,6-diazabicyclo[3.1.1]heptaines as neuronal nicotinic acetycholine receptor ligands
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 573